Hiligsmann M - Search Results

1

Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia.

Chan HY, Wijnen BFM, Hiligsmann M, Smit F, Leenen LAM, Majoie MHJM, Evers SMAA. Chan HY, et al. Among authors: hiligsmann m. Expert Rev Pharmacoecon Outcomes Res. 2022 Jul;22(5):795-803. doi: 10.1080/14737167.2021.1981861. Epub 2021 Sep 26. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34553651

2

Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women.

Hiligsmann M, Boonen A, Dirksen CD, Ben Sedrine W, Reginster JY. Hiligsmann M, et al. Expert Rev Pharmacoecon Outcomes Res. 2013 Feb;13(1):19-28. doi: 10.1586/erp.12.76. Expert Rev Pharmacoecon Outcomes Res. 2013. PMID: 23402442 Review.

3

Eliciting patients' preferences for epilepsy diagnostics: a discrete choice experiment.

Wijnen BF, de Kinderen RJ, Colon AJ, Dirksen CD, Essers BA, Hiligsmann M, Leijten FS, Ossenblok PP, Evers SM. Wijnen BF, et al. Among authors: hiligsmann m. Epilepsy Behav. 2014 Feb;31:102-9. doi: 10.1016/j.yebeh.2013.11.029. Epub 2014 Jan 3. Epilepsy Behav. 2014. PMID: 24389020

4

Cost-effectiveness of vitamin D and calcium supplementation in the treatment of elderly women and men with osteoporosis.

Hiligsmann M, Ben Sedrine W, Bruyère O, Evers SM, Rabenda V, Reginster JY. Hiligsmann M, et al. Eur J Public Health. 2015 Feb;25(1):20-5. doi: 10.1093/eurpub/cku119. Epub 2014 Aug 5. Eur J Public Health. 2015. PMID: 25096255

5

Risk of bias in trial-based economic evaluations: identification of sources and bias-reducing strategies.

Evers SM, Hiligsmann M, Adarkwah CC. Evers SM, et al. Among authors: hiligsmann m. Psychol Health. 2015 Jan;30(1):52-71. doi: 10.1080/08870446.2014.953532. Epub 2014 Oct 21. Psychol Health. 2015. PMID: 25141273 Review.

6

A systematic review of cost-effectiveness analyses of drugs for postmenopausal osteoporosis.

Hiligsmann M, Evers SM, Ben Sedrine W, Kanis JA, Ramaekers B, Reginster JY, Silverman S, Wyers CE, Boonen A. Hiligsmann M, et al. Pharmacoeconomics. 2015 Mar;33(3):205-24. doi: 10.1007/s40273-014-0231-1. Pharmacoeconomics. 2015. PMID: 25377850 Review.

7

Discrete-choice experiments versus rating scale exercises to evaluate the importance of attributes.

Wijnen BF, van der Putten IM, Groothuis S, de Kinderen RJ, Noben CY, Paulus AT, Ramaekers BL, Vogel GC, Hiligsmann M. Wijnen BF, et al. Among authors: hiligsmann m. Expert Rev Pharmacoecon Outcomes Res. 2015;15(4):721-8. doi: 10.1586/14737167.2015.1033406. Epub 2015 Apr 3. Expert Rev Pharmacoecon Outcomes Res. 2015. PMID: 25835045 Clinical Trial.

8

Economic evaluations of interventions to manage hyperphosphataemia in adult haemodialysis patients: A systematic review.

Rizk R, Hiligsmann M, Karavetian M, Evers SM. Rizk R, et al. Among authors: hiligsmann m. Nephrology (Carlton). 2016 Mar;21(3):178-87. doi: 10.1111/nep.12584. Nephrology (Carlton). 2016. PMID: 26246269 Review.

9

Physicians' views on pay-for-performance as a reimbursement model: a quantitative study among Dutch surgical physicians.

Alqasim KM, Ali EN, Evers SM, Hiligsmann M. Alqasim KM, et al. Among authors: hiligsmann m. J Med Econ. 2016;19(2):148-57. doi: 10.3111/13696998.2015.1105231. Epub 2015 Nov 6. J Med Econ. 2016. PMID: 26442431 Free article.

10

Risk of bias in model-based economic evaluations: the ECOBIAS checklist.

Adarkwah CC, van Gils PF, Hiligsmann M, Evers SM. Adarkwah CC, et al. Among authors: hiligsmann m. Expert Rev Pharmacoecon Outcomes Res. 2016 Aug;16(4):513-23. doi: 10.1586/14737167.2015.1103185. Epub 2015 Nov 20. Expert Rev Pharmacoecon Outcomes Res. 2016. PMID: 26588001 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

298 results

Search Page